(HealthDay)—Retacrit (epoetin alfa-epbx) has been approved by the U.S. Food and Drug Administration as the first "biosimilar" to the anemia drugs Epogen and Procrit.
May 15, 2018
Research by Stephanie Borgland at the University of Calgary shows that giving rats unrestricted access to unhealthy foods for extended periods not only leads to obesity, but also to brain changes that makes food more attractive ...
May 15, 2018
A team of researchers including investigators from Mayo Clinic has identified a technology to address the problem of false positives in CT-based lung cancer screening. The team's findings are published in the current issue ...
May 15, 2018
A survey of LGBTQ teenagers across the nation reveals in detail the persistent challenges many of them face going about their daily lives at home, at school, and in their communities.
May 15, 2018
